Surgery Partners Inc
For the period ended Dec 31, 2023. Filed Feb 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 26, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| SURGERY PARTNERS, INC. | |
|---|---|
| By: | /s/ J. Eric EvansJ. Eric EvansChief Executive Officer(Principal Executive Officer) |
Date: February 26, 2024
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| SIGNATURES | TITLE | DATE |
|---|---|---|
| Chief Executive Officer, Director (Principal Executive Officer) | February 26, 2024 | |
| /s/ J. Eric Evans | ||
| J. Eric Evans | ||
| Executive Vice President and Chief Financial Officer(Principal Financial and Accounting Officer) | February 26, 2024 | |
| /s/ David T. Doherty | ||
| David T. Doherty | ||
| Chairman of the Board | February 26, 2024 | |
| /s/ Wayne S. DeVeydt | ||
| Wayne S. DeVeydt | ||
| Director | February 26, 2024 | |
| /s/ T. Devin O'Reilly | ||
| T. Devin O'Reilly | ||
| Director | February 26, 2024 | |
| /s/ Teresa DeLuca | ||
| Teresa DeLuca | ||
| Director | February 26, 2024 | |
| /s/ John A. Deane | ||
| John A. Deane | ||
| Director | February 26, 2024 | |
| /s/ Brent Turner | ||
| Brent Turner | ||
| Director | February 26, 2024 | |
| /s/ Andrew Kaplan | ||
| Andrew Kaplan | ||
| Director | February 26, 2024 | |
| /s/ Clifford G. Adlerz | ||
| Clifford G. Adlerz | ||
| Director | February 26, 2024 | |
| /s/ Blair E. Hendrix | ||
| Blair E. Hendrix | ||
| Director | February 26, 2024 | |
| /s/ Patricia A. Maryland, Dr.PH | ||
| Patricia A. Maryland, Dr.PH | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.